miR-223 expression is a modulator of the hematopoietic lineage differentiation.
miR-223 is a biomarker and therapeutic target in cancer and inflammation.
miR-223 is deregulated in damaged smooth, skeletal and cardiac muscles.
Macrophages export miR-223 towards recipient cells, such as hepatocytes.